Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
29,640
Total Claims
$3.1M
Drug Cost
697
Beneficiaries
$4,437
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-97%
Opioid rate vs peers
0.1% vs 2.2% avg
+214%
Cost per patient vs peers
$4,437 vs $1,411 avg
+63%
Brand preference vs peers
17.3% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
21
Opioid Claims
$64
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 5,093 claims · $2.6M
Generic: 24,379 claims · $460K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Icosapent Ethyl | 1,756 | $665K |
| Dapagliflozin Propanediol | 552 | $405K |
| Sitagliptin Phosphate | 418 | $280K |
| Diclofenac Epolamine | 507 | $213K |
| Tenofovir Alafenamide | 109 | $183K |
| Sitagliptin Phos/Metformin Hcl | 242 | $136K |
| Denosumab | 75 | $129K |
| Rivaroxaban | 121 | $88K |
| Cyclosporine | 126 | $88K |
| Empagliflozin | 95 | $59K |
| Linagliptin | 60 | $47K |
| Linaclotide | 68 | $43K |
| Linagliptin/Metformin Hcl | 71 | $37K |
| Halobetasol Propionate | 410 | $36K |
| Raloxifene Hcl | 522 | $34K |
Prescribing Profile
Patient Profile
73
Avg Age
50%
Female
0.96
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data